Founders

 

Cure Leukaemia was founded in 2002 by Professor Charlie Craddock CBE and two patients, Michael Woolley and Graham Silk, to allow patients with blood cancer access to the remarkably effective and potentially life-saving new treatments which were becoming available.

 

Whilst Professor Charlie Craddock and Graham Silk remain involved as trustees, Michael Woolley was chair for the first six years of the charity’s life and in that role, played an important part in the early years of the charity which set the foundations which enabled Cure Leukaemia to grow into the charity it has now become.

Professor Charlie Craddock CBE is also the Medical Director of Cure Leukaemia.

What we do

The Trials Acceleration Programme (TAP)

How funds raised for Cure Leukaemia help save lives

Cure Leukamia Pre footer image
"Cure Leukaemia’s funding of the UK Trials Acceleration Programme (TAP) is a game-changer and increases the access for blood cancer patients to potentially transformative new therapies."

Sir John Bell
"Cure Leukaemia’s funding of the UK Trials Acceleration Programme (TAP) is a game-changer and increases the access for blood cancer patients to potentially transformative new therapies."

Sir John Bell